Fengyuan Qian

301 Yanchang Middle Road
Shanghai, 200072, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Decoding the immunometabolic landscape identifies SLC7A5 as a vulnerability in chemo-immunotherapy resistant TNBC.

Decoding the immunometabolic landscape identifies SLC7A5 as a vulnerability in chemo-immunotherapy resistant TNBC.

Journal: Clinical and experimental medicine

Published: April 19, 2026

Lactate-Driven Restriction of Mitochondrial Permeability Transition Promotes Resistance to Chemo-Immunotherapy by Suppressing Tumor PANoptosis.

Lactate-Driven Restriction of Mitochondrial Permeability Transition Promotes Resistance to Chemo-Immunotherapy by Suppressing Tumor PANoptosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 18, 2026

Identification of RPL4 as a biomarker associated with disulfidptosis and arachidonic acid metabolism in breast cancer.

Identification of RPL4 as a biomarker associated with disulfidptosis and arachidonic acid metabolism in breast cancer.

Journal: Discover oncology

Published: October 28, 2025

Corrigendum to "Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages" [J. Adv. Res. 69 (2025) 125-138].

Corrigendum to "Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages" [J. Adv. Res. 69 (2025) 125-138].

Journal: Journal of advanced research

Published: May 11, 2025

High Sugar Induced RCC2 Lactylation Drives Breast Cancer Tumorigenicity Through Upregulating MAD2L1.

High Sugar Induced RCC2 Lactylation Drives Breast Cancer Tumorigenicity Through Upregulating MAD2L1.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 23, 2024

DLAT promotes triple-negative breast cancer progression via YAP1 activation.

DLAT promotes triple-negative breast cancer progression via YAP1 activation.

Journal: Cancer biology & therapy

Published: October 26, 2024

Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy.

Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 06, 2024

ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.

ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.

Journal: Cell death & disease

Published: January 16, 2024

Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages.

Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages.

Journal: Journal of advanced research

Published: January 11, 2024

LINC01572 promotes triple-negative breast cancer progression through EIF4A3-mediated β-catenin mRNA nuclear exportation.

LINC01572 promotes triple-negative breast cancer progression through EIF4A3-mediated β-catenin mRNA nuclear exportation.

Journal: Environmental toxicology

Published: July 13, 2023

Application of Deep Learning Technology in Glioma.

Application of Deep Learning Technology in Glioma.

Journal: Journal of healthcare engineering

Published: December 08, 2021

Establishment and verification of ceRNA network analysis and prognostic evaluation model for breast cancer.

Establishment and verification of ceRNA network analysis and prognostic evaluation model for breast cancer.

Journal: Panminerva medica

Published: September 06, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026